Key facts
- A world leader within diabetes care and haemostasis management
- Sales totalled DKK 41.8 billion in 2007 (EUR 5.6 billion)
- Volume market share in insulin 52.0% by the end of 2007 (source IMS)
- Some 25,500 full-time employees
- Focus on core areas with large unmet medical needs: Diabetes care, haemostasis management, growth disorders and other biopharmaceuticals
- Strong global marketing network
- Listed on the Copenhagen, London and New York Exchanges
